A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy

Bibliographic Details
Main Authors: DAI Mingjia, YAN Xuebing
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2015-10-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=6901
id doaj-511aad94afdb4c2bae847dc5ad53af6a
record_format Article
spelling doaj-511aad94afdb4c2bae847dc5ad53af6a2020-11-24T21:27:27ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562015-10-0131101595159810.3969/j.issn.1001-5256.2015.10.008A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy DAI Mingjia 0YAN Xuebing1Department of Infectious Diseases, The Affiliated Hospital of Xuzhou, Medical College, Xuzhou, Jiangsu 221002, ChinaDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou, Medical College, Xuzhou, Jiangsu 221002, Chinahttp://www.lcgdbzz.org/qk_content.asp?id=6901
collection DOAJ
language zho
format Article
sources DOAJ
author DAI Mingjia
YAN Xuebing
spellingShingle DAI Mingjia
YAN Xuebing
A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
Linchuang Gandanbing Zazhi
author_facet DAI Mingjia
YAN Xuebing
author_sort DAI Mingjia
title A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
title_short A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
title_full A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
title_fullStr A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
title_full_unstemmed A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy
title_sort comparative analysis of 2014 and 2015 easl guidelines for anti-hcv therapy
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2015-10-01
url http://www.lcgdbzz.org/qk_content.asp?id=6901
work_keys_str_mv AT daimingjia acomparativeanalysisof2014and2015easlguidelinesforantihcvtherapy
AT yanxuebing acomparativeanalysisof2014and2015easlguidelinesforantihcvtherapy
AT daimingjia comparativeanalysisof2014and2015easlguidelinesforantihcvtherapy
AT yanxuebing comparativeanalysisof2014and2015easlguidelinesforantihcvtherapy
_version_ 1725974573078282240